V
48.62
-2.02 (-3.99%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看涨 | 混合的 |
| Biotechnology (全球的) | 看涨 | 混合的 | |
| 股票 | Vera Therapeutics, Inc. | 看涨 | 看涨 |
AIStockmoo 评分
-0.1
| 分析师共识 | 1.5 |
| 内部交易活动 | NA |
| 价格波动 | -3.0 |
| 技术平均移动指标 | 1.5 |
| 技术振荡指标 | -0.5 |
| 平均 | -0.13 |
|
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Growth |
| 内部持股比例 | 3.97% |
| 机构持股比例 | 112.39% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 97.00 (Evercore ISI Group, 99.51%) | 购买 |
| 中 | 84.00 (72.77%) | |
| 低 | 33.00 (Wedbush, -32.13%) | 保留 |
| 平均值 | 76.67 (57.69%) | |
| 总计 | 5 购买, 1 保留 | |
| 平均价格@调整类型 | 48.27 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| B of A Securities | 19 Dec 2025 | 66.00 (35.75%) | 购买 | 51.22 |
| Goldman Sachs | 19 Dec 2025 | 95.00 (95.39%) | 购买 | 51.22 |
| JP Morgan | 19 Dec 2025 | 96.00 (97.45%) | 购买 | 51.22 |
| Wedbush | 11 Dec 2025 | 33.00 (-32.13%) | 保留 | 46.02 |
| Evercore ISI Group | 08 Dec 2025 | 97.00 (99.51%) | 购买 | 45.03 |
| TD Cowen | 05 Dec 2025 | 73.00 (50.14%) | 购买 | 44.90 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合